Skip to content

Ashland ASH Add - Incremental shares under stock-based compensation plans (in shares)

Add - Incremental shares under stock-based compensation plans (in shares) at other companies

Minerals Technologies logo
Minerals TechnologiesMTX
$0
Innospec logo
InnospecIOSP
HWK
HawkinsHWKN
Ingredion logo
IngredionINGR
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$482.0M+0.6%
Gross profit$147.0M0.0%
Operating income$39.0M-23.5%
Net income$16.0M-48.4%
EPS (diluted)$0.34-47.7%

Balance sheet

See full
Cash & equivalents$343.0M+104%
Total debt$1.5B-0.6%
Total equity$1.9B-27.1%
Total assets$4.5B-14.0%

Cash flow

See full
Operating cash flow$50.0M+456%
CapEx$17.0M-19.0%
Free cash flow$33.0M+375%

Valuation

See full
Market cap$2.93B-9.0%
Enterprise value$4.06B-10.6%
P/S1.6×0.0×

Profitability

See full
Gross margin30%-1.7pp
Operating margin-37.3%
Net margin-40.8%-48.8pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity-33.4%-38.5pp
Debt / equity0.8×+0.2×
Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's add - incremental shares under stock-based compensation plans (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ashland's add - incremental shares under stock-based compensation plans (in shares)?
Ashland (ASH) reported add - incremental shares under stock-based compensation plans (in shares) of $0 in Q1 2026.